Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis

Overview of attention for article published in Inflammation Research, October 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

COMPOSITION FOR INHIBITING INFLAMMATION ASSOCIATED WITH MOBILIZATION OF IMMUNE CELL BY…

Application JP-2023082437-A

Japan

14 Jun 2023

USE OF ETV3 OR ETV6 INHIBITORS FOR BLOCKING THE DIFFERENTIATION OF MONOCYTES INTO…

Application WO-2023031242-A1

World Intellectual Property Organisation (WIPO)

09 Mar 2023

Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor…

Grant US-10980739-B2

United States of America

20 Apr 2021

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A CHEMOKINE/CHEMOKINE RECEPTOR…

Application WO-2018112264-A1

World Intellectual Property Organisation (WIPO)

21 Jun 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.